What is pyoderma gangrenosum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pyoderma Gangrenosum?

Pyoderma gangrenosum (PG) is a rare, painful neutrophilic dermatosis characterized by rapidly developing necrotic skin ulcerations with undermined borders, purulent material that is sterile on culture, and a strong association with systemic inflammatory diseases, particularly inflammatory bowel disease. 1

Clinical Presentation

Lesion Characteristics:

  • Initially presents as single or multiple erythematous papules or pustules that rapidly progress to deep excavating ulcerations 1
  • The ulcers contain purulent material that is sterile on culture unless secondary wound infection has occurred 1
  • Hallmarked by undermined, irregular, erythematous-violaceous borders with peripheral erythema 2, 3
  • Lesions are preceded by trauma at the site in 20-30% of cases through a phenomenon called pathergy 1, 4

Common Locations:

  • Most frequently affects the lower extremities, particularly the shins 1, 5
  • Can occur anywhere on the body including genitalia 1
  • Adjacent to stomas (peristomal PG) 1

Epidemiology and Associated Conditions

Demographics:

  • Average age of onset is in the mid-40s, affecting the third to sixth decades of life 5, 3
  • Incidence of a few cases per million person-years 3
  • Affects men and women almost equally 5

Systemic Disease Associations:

  • 50-70% of cases are associated with underlying systemic disorders 4
  • Occurs in 0.6-2.1% of ulcerative colitis patients, with higher frequency than in Crohn's disease 1, 4
  • Commonly associated with inflammatory bowel disease, hematological malignancies, and rheumatologic disorders 4
  • PG may precede the diagnosis of the underlying condition, particularly IBD 4

Pathophysiology

Immune Dysregulation:

  • Considered an autoinflammatory disorder within the spectrum of neutrophilic dermatoses 1, 6, 3
  • Involves profound dysregulation of both innate and adaptive immunity 2
  • T helper 17/T helper 1-skewed inflammation with exaggerated inflammasome activation 2
  • Dysregulated neutrophil-dominant milieu with elevated levels of TNF-α, IL-1β, IL-8, IL-17, IL-23, and IL-36 2
  • Abnormal neutrophil function and impaired cellular immunity play key roles 4

Diagnosis

Diagnostic Approach:

  • PG is a diagnosis of exclusion with no specific laboratory or histopathologic findings to confirm diagnosis 5
  • Biopsy from the periphery of the lesion is recommended to help exclude other disorders, though findings are non-specific 7, 4
  • Histology reveals non-caseating granulomas in some cases and demonstrates a perivascular and diffuse infiltrate of neutrophils 1

Critical Differential Diagnoses:

  • Ecthyma gangrenosum (bacterial cutaneous vasculitis requiring antibiotics, not immunosuppression) presents as painless erythematous papules progressing to painful necrotic lesions within 24 hours, whereas PG is a sterile inflammatory process 7
  • Infection, vascular insufficiency ulcers, systemic vasculitides, autoimmune disease, and malignancy 5
  • Metastatic Crohn's disease, which may appear as nodules, plaques, or ulcers with non-caseating granulomas on histology 1

Clinical Spectrum

Related Neutrophilic Dermatoses:

  • PG forms part of the spectrum of neutrophilic dermatoses associated with IBD, which includes Sweet's syndrome, pustular eruption of ulcerative colitis, and bowel-associated dermatosis-arthritis syndrome 1
  • Sweet's syndrome is characterized by tender, red inflammatory nodules or papules, usually affecting upper limbs, face, or neck, with strong predilection for women and patients with colonic involvement 1

Common Pitfalls

Misdiagnosis Risk:

  • Misdiagnosis occurs in a substantial percentage of cases 7
  • The disease is frequently misdiagnosed and often requires work-up for underlying systemic disease 5

Surgical Intervention:

  • Avoid surgical debridement during active disease due to pathergy, as trauma can trigger new lesion development 7
  • Surgical intervention should be reserved for after disease control or for progressive necrotizing fasciitis 7

Recurrence:

  • High recurrence rate of more than 25% following successful treatment, with recurrences often occurring in the same location as the initial episode 7, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pyoderma gangrenosum.

Nature reviews. Disease primers, 2020

Guideline

Pyoderma Gangrenosum Associations and Pathophysiology

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Etiology and management of pyoderma gangrenosum: a comprehensive review.

American journal of clinical dermatology, 2012

Guideline

Treatment Approach for Pyoderma Gangrenosum

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.